Individual patient data meta-analysis of NEPA versus aprepitant-based antiemetic regimens for preventing chemotherapy-induced nausea and vomiting Article Swipe
Related Concepts
Aprepitant
Antiemetic
Nausea
Medicine
Chemotherapy-induced nausea and vomiting
Vomiting
Chemotherapy
Oncology
Internal medicine
Anesthesia
Dexamethasone
Pharmacology
Rudolph M. Navari
,
Timothy Tyler
,
Naoki Inui
,
Hirotoshi Iihara
,
Erminio Bonizzoni
,
Yeon Hee Park
,
Hope S. Rugo
,
Eric Roeland
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1080/14796694.2025.2542108
· OA: W4413054326
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1080/14796694.2025.2542108
· OA: W4413054326
Improved CINV prevention was observed with NEPA-based regimens, particularly during Days 3-5, highlighting its potential for managing prolonged nausea and vomiting associated with emerging anticancer targeted therapies.
Related Topics
Finding more related topics…